Franklin Resources Inc. lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 56.4% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 862,187 shares of the company's stock after selling 1,113,499 shares during the period. Franklin Resources Inc. owned approximately 0.51% of Option Care Health worth $26,374,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in the stock. Blue Trust Inc. lifted its stake in shares of Option Care Health by 14.8% in the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares during the period. GAMMA Investing LLC grew its position in shares of Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock valued at $28,000 after acquiring an additional 471 shares during the period. Lindenwold Advisors INC increased its stake in shares of Option Care Health by 5.4% in the 3rd quarter. Lindenwold Advisors INC now owns 9,548 shares of the company's stock worth $299,000 after purchasing an additional 489 shares in the last quarter. Trust Point Inc. lifted its stake in Option Care Health by 2.6% in the third quarter. Trust Point Inc. now owns 24,124 shares of the company's stock worth $755,000 after purchasing an additional 622 shares during the last quarter. Finally, Orion Portfolio Solutions LLC boosted its holdings in Option Care Health by 2.3% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 28,232 shares of the company's stock valued at $884,000 after acquiring an additional 636 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on the stock. The Goldman Sachs Group lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and cut their price objective for the company from $38.00 to $27.00 in a report on Monday, November 4th. UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They set a "neutral" rating and a $26.00 price objective for the company. JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research note on Monday, September 30th. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a research report on Thursday, October 31st. Finally, Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $30.14.
Read Our Latest Stock Report on Option Care Health
Insider Activity
In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company's stock, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.64% of the company's stock.
Option Care Health Stock Performance
OPCH stock traded up $0.30 during trading on Friday, reaching $22.91. The company had a trading volume of 5,020,286 shares, compared to its average volume of 1,586,333. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 19.25, a price-to-earnings-growth ratio of 2.45 and a beta of 1.33. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63. The firm has a 50-day simple moving average of $24.96 and a 200-day simple moving average of $28.29.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.